Keyphrases
B Cell Development
25%
CD8+ T Cells
25%
Disease Burden
25%
Enhanced Immunogenicity
100%
Epitope
25%
Gene Expression
25%
Gene Segment
25%
Immune Response
25%
Immunogenicity
50%
Influenza
25%
Influenza Vaccine
25%
Influenza Virus
100%
Live Vaccine
25%
MicroRNA
50%
MicroRNA-155 (miR-155)
100%
Molecular Adjuvant
25%
Neutralizing Antibodies
25%
Non-coding RNA (ncRNA)
25%
NS Gene
25%
Recombinant Influenza Virus
25%
Self-adjuvanting
25%
T Cell Development
25%
Vaccine Effectiveness
25%
Virus Genome
100%
β-cell Function
25%
Immunology and Microbiology
Adjuvant
33%
Attenuated Vaccine
33%
B Cell Development
33%
Cell Function
33%
Cytotoxic T-Cell
33%
Disease Burden
33%
Epitope
33%
Gene Expression
33%
Immune Response
33%
Immunogenicity
100%
Influenza
66%
Influenza Virus
33%
Influenzavirus A
100%
Live Vaccine
33%
Neutralizing Antibody
33%
T Cell Development
33%
Vaccine Efficacy
33%
Virus Genome
100%